A new study published in PLOS Medicine highlights a cost-effective strategy to boost human papillomavirus (HPV) vaccine uptake among adolescents. The randomized controlled trial, conducted in China, examined a “pay-it-forward” model where participants received a subsidized vaccine and had the opportunity to donate to help others. The study found that this prosocial approach significantly increased the HPV vaccination rate among girls aged 15-18, from 17.5% in the control group to 34.2% in the pay-it-forward group. This method not only improved vaccine uptake but also enhanced vaccine confidence and reduced the cost per person vaccinated compared to the control arm.
The findings from this trial are particularly relevant for low- and middle-income countries (LMICs) where financial barriers often hinder access to catch-up vaccination for older adolescents. The study’s authors suggest that the pay-it-forward model, which also fosters community engagement, could be a valuable tool for health systems aiming to improve vaccination rates. This approach demonstrates a potential path forward for achieving public health goals by combining financial support with a sense of community responsibility, thereby making immunization programs more effective and sustainable.
Thumbnail image credit: Shutterstock
Any organization or individual working in the field of immunization economics can submit findings, opportunities, calls to action, or other relevant work below to be shared with our community.